Cite

HARVARD Citation

    Martinello, R. et al. (n.d.). Investigational ErbB-2 tyrosine kinase inhibitors for the treatment of breast cancer. Expert opinion on investigational drugs. pp. 393-403. [Online]. 
  
Back to record